Monoclonal gammopathy associated with visceral leishmaniasis  by Sharma, Vishal et al.
297
CA
SE
R
EP
O
R
T
Monoclonal gammopathy associated with 
visceral leishmaniasis
Authors
Vishal Sharma, MD1
Mukul P Agarwal, MD1
Subhash Giri, MD1
1Department of Medicine, 
University College of 
Medical Sciences, Delhi, 
India.
Submitted on: 03/08/2010 
Approved on: 03/15/2010
Correspondence to: 
Dr Vishal Sharma, MD
University College of 
Medical Sciences, Delhi, 
India.
19 Gobind nagar Subhash 
Road Chheharta Amritsar 
India
Phone: +91-9873093740
E-mail: docvishalsharma@
gmail.com
We declare no conﬂ ict of 
interest.
ABSTRACT
Monoclonal gammopathy can accompany diverse conditions and is usually benign. It should be dis-
tinguished from monoclonal gammopathy of undetermined signifi cance (MGUS) which can rarely 
turn malignant. Visceral leishmaniasis has only rarely been associated with monoclonal gammopa-
thy. We describe the case of a 55-year-old male who had monoclonal gammopathy associated with 
visceral leishmanisais, which reversed with stibogluconate therapy.
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INTRODUCTION
Monoclonal gammopathy can accompany a 
number of diverse conditions including infec-
tions, haematological malignancies and der-
matological conditions. Occasionally, it can be 
detected incidentally without any underlying 
predisposition and is then termed monoclonal 
gammopathy of undetermined signifi cance 
(MGUS). Only rarely has visceral leishmaniasis 
been implicated as a cause. We present the case 
of a 55-year-old male who had a monoclonal 
gammopathy associated with visceral leishma-
niasis, which reversed with therapy.
 
CASE HISTORY
A 55-year-old male presented with history of 
fever of two months duration. He had high fe-
ver associated with chills and rigors. There was 
no associated cough, expectoration, abdomi-
nal pain, loose stools, or dysuria. The patient 
had been anorexic and had lost six kilograms 
of weight over the past two months. He was 
originally a resident of Bihar (an area endemic 
for visceral leishmaniasis). He had no history 
of treatment for visceral leishmaniasis or tu-
berculosis. 
At the time of presentation, he was febrile 
(39.4o C) and appeared pale. Abdominal palpa-
tion revealed mild hepatomegaly (liver span-16 
cm) and a moderately enlarged fi rm spleen. 
His CBC revealed a normocytic normochromic 
anemia (Hb-6.9 g/dL, MCV-93.8 fL, and MCH-
29.6 pg), decreased leukocytes (1,900/cel mm3), 
and thrombocytopenia (74,000/cel mm3). Serum 
proteins were elevated with increased globulin 
levels (total protein-9.1 g/dL, albumin-3.0 g/dL, 
globulin-6.1 g/dL and A: G ratio of 1:2). Under 
clinical suspicion of visceral leishmaniasis, a bone 
marrow aspiration (BMA) was performed. BMA 
revealed LD bodies and showed a signifi cant in-
crease in number of mature plasma cells to 16%. 
In view of raised globulins and evidence of plas-
macytosis, a serum protein electrophoresis was 
done. This revealed presence of M-spike over an 
underlying polyclonal hypergammaglobuline-
mia (total protein-8.7 g/dL, albumin-3.13 g/dL, 
alpha1 globulin-0.43 g/dL, alpha2-0.44 g/dL, 
beta2-0.57 g/dL, gamma-4.13 g/dL). The serum 
calcium was 7.9 mg/dL and the skeletal survey 
was normal. Patient could not afford the further 
testing to characterize the M band. The serology 
for k39 antibody was positive and the patient was 
treated with sodium stibogluconate for a month. 
In the course of his stay, the hepatosplenom-
egaly regressed, his serum globulins had fallen 
(total proteins-7.2 g/dL, albumin-3.7 g/dL, glob-
ulin-3.5 g/dL). His hematological parameters 
improved (Hb-8.2 g/dL, TLC-6,500/mm3, and 
platelet count-120,000/mm3). Another BMA was 
done on completion of 28 days therapy and so-
dium stibogluconate revealed only 4% plasma 
cells with no LD bodies. At three months of fol-
low-up, no M spike was detected and the patient 
was asymptomatic with normal globulins (serum 
globulin-2.3 g/dL). 
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DISCUSSION
Monoclonal gammopathies are disorders associated with 
formation of M spike (band of monoclonal protein usually 
in the γ globulin region. Usually, this results from plasma 
cell disorders but might accompany a variety of diseases in-
cluding solid tumors (colon, breast), sarcoidosis, parasitic 
diseases, rheumatoid arthritis, AIDS, chronic liver disease 
(especially HCV related), lichen myxedematosus, pyoderma 
gangrenosum, etc.1
Polyclonal hypergammaglobulinemia is a common fea-
ture of visceral leishmaniasis. Only a few case reports in the 
past have implicated visceral leishmaniasis as an etiology of 
monoclonal gammopathy.2-4 In one case, the patient had a 
monoclonal triple band.2 In few cases BMA did not reveal 
LD bodies, and antileishmanial serology was utilized to es-
tablish the diagnosis. In two of the published cases, as well 
as in our case, BMA revealed plasmacytosis that disappeared 
with therapy.2,3 Visceral leishmaniasis has also been impli-
cated as a cause of cryoglobulinemia.5 These manifestations 
of visceral leishmaniasis have been proposed to be a result of 
chronic antigenic stimulation that occurs in these patients.4
Monoclonal gammopathy associated with visceral 
leishmaniasis should be distinguished from monoclonal 
gammopathy of undetermined significance (MGUS). 
MGUS is usually detected incidentally but is known to 
progress to malignancy with time.1 Also, the monoclonal 
protein in MGUS does not disappear with time, and 
yearly screening should be done to rule out transforma-
tion into malignant monoclonal gammopathy. In con-
trast, M spike in visceral leishmaniasis disappears with 
therapy. Moreover, the recognition of this correlation is 
important in endemic areas because patients detected 
as having M component might be harbouring leishma-
niasis. The reported case of visceral leishmaniasis is rare 
one, but is a potentially treatable cause of monoclonal 
gammopathy; therefore, it should be considered in the 
differential diagnosis of monoclonal gammopathy, espe-
cially in endemic areas.
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